Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
137
days
FIRL potentiates antibiotic activity against multidrug-resistant Gram-negative bacteria: Selective BamA–BamD interface perturbation induces functional outer membrane vulnerability
AuthorsWenwen Li; Bingjie Ji; Weixuan Wen; Jiale Tuo; Shangxiao Li; Yue Wu; Siying Qin; Hongtong Chen; Jin Luo; Jinghai Zhang; Xinyi Yang; Yongshan Zhao
AffiliationsSchool of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning, China; Postdoctoral Research Station of Clinical Medicine, Hebei Medical University, Shijiazhuang, Hebei, China; School of Medical Devices, Shenyang Pharmaceutical University, Benxi, Liaoning, China; Beijing Key Laboratory of Antimicrobial Agents/Laboratory of Pharmacology/State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Division for Medicinal Microorganism-Related Strains, CAMS Collection Center of Pathogenic Microorganisms, Beijing, China; Army Infantry Academy, Nanchang, China
158
days
Celastrol inhibits Streptococcus suis infection through disrupting arginine metabolism pathway
AuthorsHongdou Liu; Shichao Xu; Rui Lei; Xiaoying Yu; Yi Lu; Yandi Pan; Bo Su; Shiqi Lang; Hongkai Ren; Rendong Fang; Jialu Zhang; Lianci Peng
AffiliationsJoint International Research Laboratory of Animal Health and Animal Food Safety, Southwest University, Chongqing, China; National Center of Technology Innovation for Pigs, Chongqing, China
125
days
Impact of timing of aggressive joint PK/PD target attainment of continuous infusion piperacillin-tazobactam on early clinical response of febrile neutropenia to antimicrobial treatment: Insights from a prospective, monocentric, observational study in paediatric hematopoietic stem cell recipients
AuthorsMilo Gatti; Davide Leardini; Caterina Campoli; Francesco Venturelli; Carolina Patrucco; Tamara Belotti; Francesco Baccelli; Maddalena Giannella; Riccardo Masetti; Pierluigi Viale; Marcello Lanari; Federico Pea
AffiliationsDepartment of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy; Clinical Pharmacology Unit, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Infectious Diseases Unit, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
53
days
Early prediction of carbapenem resistance phenotype in ICU-acquired Acinetobacter baumannii infection before susceptibility reporting: A temporally validated study
AuthorsMeng Zhou; Yaling Zhou; Chengxiang Xiang; Yiting Liu; Dongbo Li; Liru Zhao; Zuchen Zeng; Pengfeng Ding; Hongyu Bian; Zhongle Cheng
AffiliationsDepartment of Laboratory Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China; Anhui Provincial Public Health Clinical Center, Hefei, Anhui, China; Hefei Maternity and Child Health Hospital, Anhui Province, Hefei, Anhui, China; The First School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, China
68
days
Precision redosing of oritavancin: A population pharmacokinetic framework to optimize long-term therapy for complex gram-positive infections
AuthorsSimone Giuliano; Antonio D'Avolio; Jacopo Angelini; Amedeo de Nicolò; Sara Ferin; Camilla Martino; Luca Martini; Maria Merelli; Francesco Russiani; Carlo Tascini; Manjunath P. Pai
AffiliationsInfectious Diseases Division, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin - ASL “Città di Torino”, Turin, Italy; Clinical Pharmacology and Toxicology Institute, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy; Department of Medicine (DMED), University of Udine, Udine, Italy; Department of Clinical Pharmacy, University of Michigan, College of Pharmacy, Ann Arbor, MI, USA
112
days
Antimicrobial prophylaxis regimens in joint replacement surgery: Susceptibility and PK/PD target attainment
AuthorsAlba Rivera; Sonia Luque; Isabel Mur; Lluís Puig-Verdié; Anna Gállego; Xavier Crusi; Luisa Sorlí; José Carlos González; Juan Pablo Horcajada; Ferran Navarro; Jason A. Roberts; Natividad Benito
AffiliationsDepartment of Microbiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain; Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Pharmacy, Hospital del Mar, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain; Department of Internal Medicine, Infectious Diseases Unit, Hospital Moisès Broggi, Sant Joan Despí, Spain; Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC), Madrid, Spain; Department of Orthopaedic Surgery and Traumatology, Hospital del Mar, Barcelona, Spain; Department of Internal Medicine, Fundació Hospital de l’Esperit Sant, Santa Coloma de Gramenet, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Orthopaedic Surgery and Traumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Infectious Diseases, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; Metro North Health, Herston Infectious Diseases Institute (HeIDI), Brisbane, Queensland, Australia; Department of Intensive Care Medicine and Pharmacy, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France
129
days
Pharmacogenomic variability in adolescents and youth with virologic rebound while receiving injectable cabotegravir/rilpivirine: A multi-case series
AuthorsTimothy J. Howze; Susan D. Carr; Nehali D. Patel
AffiliationsDepartement of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, USA; Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN, USA
138
days
Optimising the meropenem dosing regimen in neonates: A dual-centre cohort study
AuthorsTao Zhang; Hua Cheng; Xinyan Han; Qian Du; Jiaojiao Chen; Yulan Qiu; Taotao Wang; Yalin Dong
AffiliationsKey Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi’an Jiaotong University, Xi’an, Shaanxi, China; Department of Pharmacy, College of Stomatology, Xi’an Jiaotong University, Xi’an, Shaanxi, China; Department of Pharmacy, the Affiliated Children Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China; Department of Pharmacy, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China
102
days
An exploration of the effectiveness and safety of 7‑d triple therapy with amoxicillin and tetracycline for Helicobacter pylori eradication: A propensity score matching analysis
AuthorsKunping Ju; Baobao Wang; Qingzhou Kong; Yueyue Li; Xiuli Zuo; Yanqing Li
AffiliationsDepartment of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China; Shandong Provincial Clinical Research Center for Digestive Disease, Jinan, Shandong, China; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China; Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, Shandong, China
143
days
The T6SS effector Hcp of hypervirulent Klebsiella pneumoniae exacerbates liver abscess by inducing macrophage-HMGB1/RAGE-dependent endothelial pyroptosis
AuthorsBo Ni; Zhaoyu Liu; Zhihui Chang; Hairui Wang
AffiliationsDepartment of Radiology, Shengjing Hospital of China Medical University, Shenyang, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days